Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04DZD
|
||||
| Former ID |
DIB006193
|
||||
| Drug Name |
Bidisomide
|
||||
| Synonyms |
Butanamide; SC-40230
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Heart arrhythmia [ICD10:I47-I49] | Discontinued in Phase 3 | [1] | ||
| Company |
GD Searle & Co
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H34ClN3O2
|
||||
| Canonical SMILES |
C(C(=O)N)(c1c(Cl)cccc1)(CCN(C(=O)C)C(C)C)CCN1CCCCC1
|
||||
| CAS Number |
CAS 116078-65-0
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [2] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000174) | ||||
| REF 2 | Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics. Clin Pharmacol Ther. 1992 Apr;51(4):371-8. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.